Diagnosis and treatment of primary aldosteronism

World Journal of Urology

Volumn 17, Issue 1, 1999, Pages 15-21

  Blumenfeld, Jon D ^a   Darracott Vaughan, E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERALDOSTERONISM; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERALDOSTERONISM;

EID: 0033069450     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450050099     Document Type: Article

References (29)

1. Arteaga E. Biglieri EG, Kater CE, et al (1984) Aldosteroneproducing adrenocortical carcinoma: preoperative recognition and course in 3 cases. Ann Intern Med 101: 316
2. Biglieri EG. Kater CE, Mantero F (1995) Adrenocortical forms of human hypertension. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management. 2nd edn. Raven, New York, pp 2145-2162
3. Blumenfeld JD. Sealey JE, Schlüssel Y, Vaughan ED Jr, et al (1994) Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 121: 885
4. Bravo EL. Dustan HP, Tarazi RC (1973) Spironolactone as a nonspecific treatment for primary aldosteronism. Circulation 48: 49198
5. Bravo EE. Dustan HP. Tarazi RC (1975) Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronism. J Clin Endocrinol Metah 41:611-617
6. Bravo EE. Tarazi RC. Dustan HP, Fouad F (1985) The sympathetic nervous system and hypertension in primary aldosteronism. Hypertension 7: 90-96
7. Celen O. O'Brien MJ. Melby JC. Beazley RM (1996) Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 131: 646-650
8. Fanestil DD (1988) Mechanism of action of aldosterone blockers. Semin Nephrol 8: 249-263
9. Fontes R, Kater C, Biglieri EG, Irony II (1991) Reassessment of the predictive value of the postural stimulation test in primary aldosteronism. Am J Hypertens 4: 786-791
10. Gasparo M de. Whitebread EE, Preiswerk G, et al (1989) Antialdosterones: incidence and prevention of sexual side effects. J Steroid Biochem 32: 223-227
11. Go H. Takeda M, Tomoyuki I. et al (1995) Laparoscopic adrenalectomy for Cushing's syndrome: comparison with primary aldosteronism. Surgery 117: 11-17
12. Gordon RD. Gomez-Sanchez CE. Hamlet SM. Tunny TJ. et al (1987) Angiotensin-responsive aldosterone producing adenoma masquerades as idiopathic aldosteronism or low renin essential hypertension. J Hypertens 5 [Suppl 5]: S103-S106
13. Gordon RD, Stowasser M, Klemm SA, et al (1995) Primary aldosteronism - some genetic, morphological, and biochemical aspects of subtypes. Steroids 60: 35-41
14. Grossman E, fel-Hashomer I, Messerli FH (1996) Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies or pseudoemergencies? JAMA 276: 1328-1331
15. Guazzoni G, Montorsi F. Bocciardi A, et al (1995) Transperitoneal laparoscopic versus open adrenalectomy for benign hyperfunctioning adrenal tumors: a comparative study. J Urol 153: 1597-1600
16. Irony I. Kater C, Biglieri. Shackelton CHL (1990) Correctable subsets of primary aldosteronism: primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens 3: 576-582
17. Kater CE, Biglieri EG, Schambelan MS, Arteaga E (1983) Studies of impaired aldosterone response to spironolactoneinduced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism. Hypertension 5 [Suppl V]: VM5-V121
18. Earagh JH. Sealey JE (1992) Renin-angiotensin-aldosterone system and the renal regulation of sodium, potassium, and blood pressure homeostasis. In: Windhager EE (ed) Handbook of physiology, section 8: renal physiology, vol II. Oxford University, New York, pp 1409-1541
19. Eifton RP (1996) Molecular genetics of human blood pressure variation. Science 272: 676-680
20. Eifton RP, Dluhy RG (1995) Inherited forms of mineralocorticoid hypertension: glucocorticoid remediable aldosteronism and the syndrome of apparent mineralocorticoid excess. In: Earagh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven, New York, pp 2163-2166
21. Eitchfield WR, Dluhy RG (1995) Primary aldosteronism. Endocrinol Metab Clin North Am 24: 593-612
22. Mantero F. Opocher G. Rocco S, Armanini D (1995) Eongterm treatment of mineralocorticoid excess syndromes. Steroids 60: 81-86
23. Melby JC (1984) Primary aldosteronism. Kidney Int 26: 769778
24. Nakada T, Kubota Y. Sasagawa I, et al (1995) Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma. J Urol 153: 1775-1780
25. Schuh J (1996) Epoxymexrenone: a new antialdosterone agent. Abstract presented at the 22nd international aldosterone conference. San Francisco, June 10-11, 1996
26. Tunny T, Gordon RD, Klemm S, Cohn D (1991) Histological and biochemical distinctiveness of atypical aldosterone producing adenoma responsive to upright posture and angiotensin. Clin Endocrinol 34: 363-369
27. Ulick S, Blumenfeld JD, Atlas SA, Wang JZ, Vaughan ED Jr (1992) The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J Clin Endocrinol Metab 76: 873-878
28. Vaughan ED Jr, Carey RM, Peach MJ, et al (1978) The renin response to diuretic therapy: a limitation of antihypertensive potential. Circ Res 42: 376-381
29. Vaughan ED Jr. Blumenfeld JD (1998) The adrenals. In: Walsh PC, Retik AB, Vaughan ED Jr. Wein AJ (eds) Campbell's urology, 7th edn. WB Saunders, Philadelphia, pp 2915 2972